Download Free Medical Parkinsons disease-The basics PowerPoint Presentation

Parkinsons disease-The basics PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Neurology, which is titled "Parkinson’s disease: The basics", to know the basics of Parkinson’s disease.

Tags : Neurology, Parkinson’s disease

Published on : Aug 18, 2021 | Views : 2240 | Downloads : 6

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Parkinson’s disease: The basics Praveen Dayalu, MD Clinical Associate Professor Department of Neurology University of Michigan
Slide 2-

The basal ganglia
Slide 3-

Basal ganglia Cerebellum
Slide 4-

Parkinsonism comprises four cardinal motor features Bradykinesia (slow and small movements). Reduced blink, face expression, and gesturing. Soft voice. Difficulty getting out of chair, shuffling steps, reduced arm swing, freezing Tremor (usually resting) “pill rolling”, often involves thumb Rigidity (different from spasticity) Postural changes. Imbalance, falls; stooped flexed posture
Slide 5-

Differential diagnosis of parkinsonism Parkinson disease (idiopathic or genetic) Parkinson-plus degenerations (dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy) Drug-induced parkinsonism (anti-dopaminergics) Rare but treatable in young people: Wilson disease and Dopa-responsive dystonia Other: “vascular” parkinsonism, brain trauma, CNS infection
Slide 6-

Drug-Induced Parkinsonism Drugs that reduce dopamine transmission Antipsychotics / antiemetics: Risperidone, haloperidol, metoclopramide, promethazine, prochlorperazine, etc. Can be indistinguishable from PD Clozapine does not seem to cause it; quetiapine appears to have low rates Management: reduce or discontinue offending agent. Can take months to resolve!
Slide 7-

Parkinson Disease (PD) Usually idiopathic Substantia nigra degeneration causes dopamine deficiency in striatum  motor symptoms Dopaminergic therapy relieves motor symptoms
Slide 8-

Parkinson disease: Common early complaints Resting tremor Writing smaller; harder to do buttons Slowness, “weakness”, limb not working well Stiff or achy limb Stoop, shuffle-walk, “dragging” leg(s) Trouble getting out of chairs or turning in bed Low or soft voice Non-motor: anosmia, dream enactment, constipation, anxiety, depression, “passiveness”
Slide 9-

PD: meds for motor symptoms L-dopa (with carbidopa) is most effective and usually best tolerated Dopamine agonists (ropinirole, pramipexole) Others have only modest benefits (MAO-B inhibitors, anticholinergics, amantadine)
Slide 10-

Early PD: When to start meds? Drugs are symptomatic, not neuroprotective or neurotoxic Level of patient function is best guide Response to dopaminergic therapy (especially l-dopa) is the best available “test” for PD ** Remember the value of exercise! **
Slide 11-

Which treatment to start? L-dopa most effective for motor symptoms in general (bradykinesia, tremor, gait changes) Family physicians can start levodopa !! Dopamine agonists cause more non-motor side effects, and are best avoided in patients above 70
Slide 12-

Treatment pearls in early PD Fear not L-dopa. “Delaying L-dopa” is of no benefit long-term. Treat more for symptoms and function, and less for how the patient “looks”. Generics are fine. Allow adequate dose and time to work before concluding “failure” or “not PD”. Resting tremor may be medication refractory in some patients; don’t conclude “not PD”.
Slide 13-

Levodopa Most effective overall for motor symptoms A fine option for initial therapy of PD By mid to late disease it is almost always needed Non-motor side effects include nausea, orthostasis, sleepiness, hallucinations; but not as much as other PD drugs Motor side effect: dyskinesias
Slide 14-

Carbidopa/ levodopa dosing Commonest preparation is regular 25/100mg. Try 1 pill PO TID  1.5 pills TID  2 pills TID. With meals reduces nausea. 2 weeks between steps to appreciate effect. No response? At least 900mg/ d to say “not PD”. Some patients need QID or more frequent dosing (even Q3H in advanced disease). Typical daily l-dopa dose range: 300mg to 1500mg
Slide 15-

Dopamine agonists (ropinirole, pramipexole, rotigotine) Can be monotherapy in early disease; need l-dopa in mid to late disease Can add to l-dopa to reduce OFF time Frequent side effects! Nausea, sleep attacks, hypotension, compulsive behaviors, LE edema  More prone than l-dopa to causing hallucinations and confusion. Caution in older or demented patients! 
Slide 16-

Mid to late PD: a tricky business More motor complications including dyskinesias and ON-OFF fluctuations More drug-resistant motor symptoms (e.g. impaired balance with falls) More nonmotor symptoms (especially dementia and hallucinations) More medications, so more side effects Managing these complexities requires experience.
Slide 17-

“Motor complications” as PD progresses Fluctuations. Medication wears off before next dose. OFF periods worse as disease progresses. Dyskinesias (usually at the peak of ON). Need larger and/or more frequent med doses, or combinations of drugs. Deep brain stimulation an option for some patients with medically refractory motor complications.
Slide 18-

Some motor symptoms may not respond to med adjustments Postural instability and falls Freezing of gait Fatigue Dysarthria, dysphagia Some tremor (!)
Slide 19-

ppt slide no 19 content not found
Slide 20-

Non-motor Symptoms Psychiatric (depression, anxiety) Autonomic (blood pressure, genitourinary, GI) Sleep (REM behavior disorder, insomnia, hypersomnia, sleep apnea) Fatigue Cognitive (psychosis, dementia) 20
Slide 21-

Why non-motor symptoms? PD affects many parts of the nervous system Earliest involvement is in gut nerve plexus, lower brainstem, and olfactory bulb Pathology moves up the brainstem, also to serotonergic, noradrenergic, and cholinergic nuclei Non-motor symptoms (e.g. anosmia, constipation, dream enactment) often predate motor symptoms 21
Slide 22-

Depression and anxiety It’s not just because of the stress of the diagnosis Motor symptoms and wearing off can interact with mood and anxiety levels Can misinterpret “poker face” as depression. Ask the patient! SSRI’s can work; avoid benzodiazepines 22
Slide 23-

Depression and anxiety: other considerations Consider support services / psychotherapy for patients and caregivers Geriatric psychiatrists usually have better expertise in this population 23
Slide 24-

Autonomic symptoms
Slide 25-

Blood pressure dysregulation Causes orthostatic hypotension and supine hypertension Syncope can occur, sometimes with injury Worse with dopamine agonists and higher doses of L-dopa Lower extremity edema may also reflect vascular dysregulation 25
Slide 26-

Recognizing orthostatic hypotension Not all have the classic lightheaded feeling Other clues: Abrupt falls Weakness, buckling, or shaking of legs or body Being dazed, confused, “goofy” Coat-hanger ache (neck and shoulders) 26
Slide 27-

Managing orthostasis: first steps Reduce or stop antihypertensives, diuretics, other offenders (including some PD meds) Don’t over-treat isolated high BPs; 3 minute orthostatic BP gives a clearer picture Water, water, salt, and water Elevate head of bed to 30 degrees Compression stockings (groan) Teach first-aid/ bystander response 27
Slide 28-

Managing orthostasis: prescription meds Fludrocortisone: retains body sodium (beware of hypokalemia) Midodrine: raises BP (beware supine hypertension) Droxidopa: turns to norepinephrine, raises BP (beware supine hypertension) 28
Slide 29-

Urinary Symptoms Urgency, frequency, nocturia are very common Obstruction/ retention are less common Incontinence is uncommon early on Pathophysiology can be complex in any given patient Confounds: age, prostate issues, motor problems 29
Slide 30-

Managing urinary symptoms Non-pharmacologic (timed voids, head of bed up for nocturia) Bladder antispasmodics: Oxybutynin, tolterodine, solifenacin, darifenacin: beware anticholinergic brain effects! Mirabegron– a novel adrenergic drug Might cause retention, especially in men Consider urology referral (can also address ED) 30
Slide 31-

Constipation in PD May predate motor symptoms by years Slow transit or outlet obstruction Step 1: reasonable dietary fiber, water Step 2: mild osmotic laxatives (e.g., polyethylene glycol) For patients not responding to conservative measures, consider specialty referral 31
Slide 32-

Sleep symptoms
Slide 33-

REM sleep behavior disorder Typically in men, often years before motor symptoms Complex movements or fighting Usually early in the morning, varying frequency Patient or bed partner injury 33
Slide 34-

REM sleep behavior disorder- treatment Treat any underlying OSA Make sleeping environment safer Melatonin 3 - 12 mg qhs helps mild to moderate symptoms Clonazepam 0.25 – 1.0 mg qhs may be needed for more severe symptoms 34
Slide 35-

Obstructive Sleep Apnea PD patients, even skinny ones, are more at risk for sleep-disordered breathing Maintain a high level of suspicion Can present with snoring, daytime somnolence, nighttime awakenings, nocturia, worsening dream enactment… 35
Slide 36-

Insomnia Can be primary or secondary Address sleep hygiene Review med list Treat nighttime motor symptoms Think about OSA Treat psychiatric comorbidities Sedative/ hypnotics: melatonin, trazodone, mirtazapine, clonazepam (if RBD) 36
Slide 37-

Hypersomnia PD increases sleep need for many patients Poor sleep at night (many causes) Think about OSA Review med list (make special note of dopamine agonists, anticholinergics, benzos, other sedatives) 37
Slide 38-

Fatigue “Tired”, “Wiped out”, “No energy” Is it: Sleepiness? Wearing off? Motor? Mood? Isolated fatigue can be disabling No established treatment, though anti- depressants and stimulants have been tried Encourage light exercise, hobbies, etc We badly need better treatments for this 38
Slide 39-

Hallucinations & Dementia in PD Complicate many longstanding PD cases Hallucinations are usually visual Main contributors are disease progression (brain pathologic changes), age, and meds Older patients much more at risk Marker for increased morbidity, mortality, and institutionalization
Slide 40-

Hallucinations and dementia in PD Assess medical state; B12, TSH Simplify med regimen. Prioritize eliminating anticholinergics and dopamine agonists. Reduce L-dopa last. Rivastigmine (cholinesterase inhibitor) FDA approved in PD dementia Antipsychotics (off label, black-box warning!): quetiapine and clozapine least likely to worsen parkinsonism
Slide 41-

Case Studies
Slide 42-

A 66-year old woman on levodopa 100mg TID plus ropinirole 4 mg TID, has only mild wearing off between doses. She often falls asleep during work meetings, and blames her poor sleep: ‘I wake up a lot to pee. Can you prescribe me Detrol?” How might we improve her daytime alertness? How might we improve her nocturia? 42
Slide 43-

A 69-year old woman with PD, CHF, HTN, and GERD is on 250mg TID of levodopa. Her prior hand tremor is much better controlled, and she usually walks around well, but her son notes increasing episodes of “severe whole body tremors”. What questions might clarify these episodes? Accordingly, what can we do about them? 43
Slide 44-

An 81 y/o man with 10 years of Parkinson disease begins to see child soldiers peering in at the windows. He takes L-dopa, ropinirole, and alprazolam. What would you do?